The size of the European Contract Research Organization Services Market is estimated to grow USD 11.35 billion by 2027 from USD 8.44 billion in 2022, at a CAGR of 6.12% from 2022 to 2027.
Clinical research, consultation, and laboratory CRO services are progressively utilized by pharmaceutical industries, which is the primary factor accelerating the European region's CRO services market. Expenses for research and development regarding the procedure of discovering, testing, and upgrading new products accelerate market growth. In Germany, the pharmaceutical industries' expenses in 2018 are likely to have increased from USD7,100.6 million in 2015 to USD 7,113.2 million, according to data published by the European Federation of Pharmaceutical Industries and Associations (EFPIA). The enormous patient count is one factor in surging the market. Growing awareness in healthcare, escalating demand for therapeutically successful products, and upgrading technologies are likely to drive the Europe CRO services market.
Factors like snowballing administrative stress on contract research organization, problems in detecting personnel with proficiency for particular projects, and the absence of highly experienced professionals are likely to restrain the CRO services market growth in Europe. Also, strict regulations for the approval of drugs may impede the market.
This research report on the European CRO services market has been segmented & sub-segmented into the following categories:
By Therapeutic Area:
Regionally, Europe has the second-largest share in the market. It can be attributed to the high-quality pharmaceutical industry standards, rapid growth in the biosimilars and biologics market, the surge in demand for outsourcing services by pharmaceutical and biopharmaceutical companies, and the rise in the number of clinical trials in this region.
UK is on top of leading the CRO services market in Europe. Vital significance towards research and development activities by the region’s superior pharmaceutical, biotechnology, and Medtech enterprises fuel this region's growth. Europe is dominating the CRO equipment growth because of an increase in non-communicable diseases like diabetes, cardiovascular diseases, cancer, and chronic diseases. Europe region accounts for a rise in non-communicable diseases, with nearly 77% of the disease stress and anxiety, which immediately enlarges CROs' stipulation to stop the frequency of the diseases.
Germany followed after the UK in driving the market growth due to the survival of top income-producing pharmaceutical companies investing a considerable amount in R & D to impel the country's market growth.
Promising companies leading the Europe Contract Research Organization (CRO) Services Market profiled in this report are Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Clinical Research Services
126.96.36.199 Phase I Clinical Research Services
188.8.131.52 Phase II Clinical Research Services
184.108.40.206 Phase III Clinical Research Services
220.127.116.11 Phase IV Clinical Research Services
5.1.3 Early-Phase Development Services
18.104.22.168 Discovery Studies
22.214.171.124 Chemistry, Manufacturing, & Control (CMC)
126.96.36.199 Preclinical Services
188.8.131.52.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
184.108.40.206.2 Toxicology Testing Services
220.127.116.11.3 Other Preclinical Services
5.1.4 Laboratory Services
18.104.22.168 Bioanalytical Testing Services
22.214.171.124 Analytical Testing Services
126.96.36.199.1 Physical Characterization
188.8.131.52.2 Raw Material Testing
184.108.40.206.3 Batch-Release Testing
220.127.116.11.4 Stability Testing
18.104.22.168.5 Other Analytical Testing Services
5.1.5 Consulting Services
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.5 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.6 Market Attractiveness Analysis, By Therapeutic Area
5.2.7 Market Share Analysis, By Therapeutic Area
5.3 End User
5.3.4 Medical Device Companiest
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Therapeutic Area
188.8.131.52 By Type
184.108.40.206 By End User
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Therapeutic Area
22.214.171.124 By End User
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Therapeutic Area
220.127.116.11 By Type
18.104.22.168 By End User
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Quintiles Transnational Holdings Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Laboratory Corporation of America Holdings
8.3 Pharmaceutical Product Development
8.4 PAREXEL International Corporation
8.5 ICON Plc
8.6 PRA Health Sciences Inc.
8.7 InVentiv Health Inc.
8.8 Charles River Laboratories International Inc.
8.9 INC Research Holdings Inc.
8.10 Wuxi PharmaTech.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.